Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald M Mikkers

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Human Gene Therapy|August 22, 2014
Cell replacement therapies: is it time to reprogram?Harald M Mikkers, Christian Freund, Christine L Mummery, et al.
Bio-Protocol|March 4, 2021
Protocol for Isolation, Stimulation and Functional Profiling of Primary and iPSC-derived Human NK CellsJanine E Melsen, Maria Themeli, Monique M van Ostaijen-Ten Dam, et al.
Stem Cell Research|June 5, 2021
Generation of three human induced pluripotent stem cell lines, LUMCi024-A, LUMCi025-A, and LUMCi026-A, from two patients with combined oxidative phosphorylation deficiency 8 and a related controlRuben W J van Helden, Matthew J Birket, Christian Freund, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|August 22, 2014
Cell replacement therapies: is it time to reprogram?Harald M Mikkers, Christian Freund, Christine L Mummery, et al.
Bio-Protocol|March 4, 2021
Protocol for Isolation, Stimulation and Functional Profiling of Primary and iPSC-derived Human NK CellsJanine E Melsen, Maria Themeli, Monique M van Ostaijen-Ten Dam, et al.
Stem Cell Research|June 5, 2021
Generation of three human induced pluripotent stem cell lines, LUMCi024-A, LUMCi025-A, and LUMCi026-A, from two patients with combined oxidative phosphorylation deficiency 8 and a related controlRuben W J van Helden, Matthew J Birket, Christian Freund, et al.
Pageof 1